Daniel Polsky, a Bloomberg Distinguished Professor with Johns Hopkins University’s Carey Business School and Bloomberg School of Public Health, was part of the committee that developed the NIH- and CDC-sponsored Framework for Equitable Allocation of COVID-19 Vaccine report, released today.
Today, the National Academies of Sciences, Engineering, and Medicine released the Framework for Equitable Allocation of COVID-19 Vaccine. The report, which was sponsored by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), recommends a four-phased allocation framework to guide the equitable distribution of a limited initial supply of COVID-19 vaccine. The report also includes recommendations for effective community engagement, risk communication, and strategies to promote vaccine acceptance; and for equitable global allocation.
Daniel Polsky, a Bloomberg Distinguished Professor with Johns Hopkins University’s Carey Business School and Bloomberg School of Public Health, was part of the 15-member committee that developed the report and an expert in health care policy and health economics. The group is co-chaired by William Foege, emeritus presidential distinguished professor of international health at the Emory Rollins School of Public Health, and Helene Gayle, president and CEO of the Chicago Community Trust. Among the factors Polsky and other committee members examined were disparities in population health; facing higher risk because of health status, occupation, or living conditions; and the geographic distribution of the active virus.
The report’s final version is available on the National Academies website.
business of health
A call to heal the healers amid crisis
business of health
Emerging technologies and greater equity to shape the future of health
business of health
Improving TB screening in India: The right incentive